GlassScriptPhysician profile
Trisha A Cockrell
NPI 1073971909
$6,188.21
in general payments reported to CMS, 2019-2025
54 companies · $1,261 in 2025
The $1,261 reported for 2025 was more than what 88% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $138 · 2022: $1,121 · 2023: $1,797 · 2024: $1,871 · 2025: $1,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,854 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,854.21 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $520.66 | 2022-2025 | Erleada, Darzalex, Tecvayli |
| Abbvie INC. | $511.17 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $437.41 | 2023-2025 | Enhertu, Calquence, Lynparza |
| Pfizer INC. | $422.49 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $369.82 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Eisai INC. | $342.49 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $279.32 | 2022-2025 | Ninlaro, Alunbrig, Iclusig |
| Glaxosmithkline, LLC. | $275.31 | 2022-2025 | Ojjaara, Jemperli, Zejula |
| Incyte Corporation | $264.29 | 2022-2023 | Jakafi |
| Daiichi Sankyo INC. | $261.07 | 2022-2025 | Enhertu, Datroway |
| Gilead Sciences, INC. | $224.10 | 2022-2025 | Trodelvy |
| Novartis Pharmaceuticals Corporation | $182.48 | 2022-2025 | |
| Array Biopharma INC | $157.09 | 2022-2024 | Braftovi, Mektovi, Lorbrena |
| Genzyme Corporation | $148.61 | 2022-2024 | |
| Genentech USA, INC. | $132.87 | 2023-2025 | Tecentriq, Columvi, Polivy |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $115.49 | 2022-2024 | Pomalyst, Reblozyl |
| Lilly USA, LLC | $110.47 | 2022-2025 | Jaypirca, Verzenio |
| Regeneron Healthcare Solutions, INC. | $107.38 | 2022-2025 | Libtayo |
| E.R. Squibb & Sons, L.L.C. | $95.42 | 2022-2024 | Opdivo, Opdualag |
| Exelixis INC. | $78.57 | 2023-2025 | Cabometyx |
| Seagen INC. | $77.84 | 2022-2023 | Tukysa, Adcetris |
| Bayer Healthcare Pharmaceuticals INC. | $73.58 | 2022-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $73.41 | 2023 | Imbruvica, Epkinly |
| Karyopharm Therapeutics INC. | $65.65 | 2023-2025 | Xpovio |
| Ipsen Biopharmaceuticals, INC | $65.61 | 2023-2025 | Onivyde, Tazverik |
| Organogenesis INC. | $62.85 | 2021 | |
| Aveo Pharmaceuticals, INC. | $55.32 | 2024 | |
| Taiho Oncology, INC. | $53.94 | 2022-2024 | |
| Stemline Therapeutics INC. | $46.85 | 2023-2025 | Orserdu |
| Acera Surgical, INC. | $40.61 | 2021 | |
| Sobi, INC | $38.79 | 2023-2024 | |
| Kyowa Kirin, INC. | $33.72 | 2023-2024 | Poteligeo |
| Blueprint Medicines Corporation | $30.00 | 2022 | |
| Tersera Therapeutics LLC | $29.81 | 2025 | Zoladex |
| Novocure INC. | $29.64 | 2023-2024 | Optune Lua (Novottf-200t), Optune |
| Rigel Pharmaceuticals, INC. | $28.87 | 2022-2023 | Tavalisse, Rezlidhia |
| Astellas Pharma US INC | $28.05 | 2024 | Padcev |
| Jazz Pharmaceuticals INC. | $24.92 | 2024 | |
| Geron Corporation | $24.85 | 2025 | Rytelo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $24.76 | 2023 | Gilotrif |
| Amgen INC. | $21.91 | 2023 | Kyprolis |
| Puma Biotechnology, INC. | $20.42 | 2024 | |
| Alcresta Therapeutics, INC. | $19.40 | 2023 | Relizorb |
| Foundation Medicine, INC. | $18.71 | 2023 | |
| Nabriva Therapeutics, Plc | $18.24 | 2021 | |
| Genmab U.S., INC. | $17.73 | 2024 | Tivdak |
| Smith+Nephew, INC. | $17.14 | 2022 | |
| G1 Therapeutics, INC. | $17.02 | 2023 | Cosela |
| Lifenet Health | $16.49 | 2024 | Theragenesis Wound Matrix |
| Biocon Biologics INC | $16.33 | 2024 | Ogivri |
| Paratek Pharmaceuticals, INC. | $16.17 | 2021 | |
| Hologic Sales and Service, LLC | $15.54 | 2023 | Coolseal Generator |
| Telix Pharmaceuticals | $14.78 | 2023 | Illuccix |
| Global Blood Therapeutics, INC. | $12.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trisha Cockrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.